Bionano Genomics (BNGO) Other Non-Current Assets (2020 - 2026)

Bionano Genomics has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $2.7 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $2.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (changed N/A YoY), and the FY2025 annual result was $2.7 million, down 2.18% from the prior year.
• Other Non-Current Assets came in at $2.7 million for Q1 2026 at Bionano Genomics, down from $2.7 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $11.4 million in Q2 2024 to a low of $400000.0 in Q4 2022.
• The 5-year median for Other Non-Current Assets is $400000.0 (2022), against an average of $2.0 million.
• Across the five-year window, Other Non-Current Assets surged 2752.0% in 2024 and tumbled 81.69% in 2025, its largest moves.
• Bionano Genomics' Other Non-Current Assets stood at $400000.0 in 2022, then changed by 0.0% to $400000.0 in 2023, then surged by 588.5% to $2.8 million in 2024, then decreased by 2.18% to $2.7 million in 2025, then retreated by 0.59% to $2.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.7 million (Q1 2026), $2.7 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.